000			01740 a2200517 4500
005			20250517204012.0
264		0	_c20180628
008			201806s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0193542 _2doi
040			_aNLM _beng _cNLM
100	1		_aGray, Marcus A
245	0	0	_aAnti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases. _h[electronic resource]
260			_bPloS one _c2018
300			_ae0193542 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdalimumab _xtherapeutic use
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAffect _xdrug effects
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aBrain _xdrug effects
650	0	4	_aBrain Mapping
650	0	4	_aCognition _xdrug effects
650	0	4	_aCrohn Disease _xdrug therapy
650	0	4	_aDiagnostic Self Evaluation
650	0	4	_aFemale
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aInfliximab _xtherapeutic use
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aNeuropsychological Tests
650	0	4	_aRandom Allocation
650	0	4	_aSatiation _xdrug effects
650	0	4	_aTumor Necrosis Factor-alpha _ximmunology
650	0	4	_aVisceral Afferents _xdrug effects
650	0	4	_aYoung Adult
700	1		_aChao, Che-Yung
700	1		_aStaudacher, Heidi M
700	1		_aKolosky, Natasha A
700	1		_aTalley, Nicholas J
700	1		_aHoltmann, Gerald
773	0		_tPloS one _gvol. 13 _gno. 3 _gp. e0193542
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0193542 _zAvailable from publisher's website
999			_c28158401 _d28158401